January 26, 2021 08:54 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Shinzo Abe, SP Balasubrahmanyam and 5 others awarded Padma Vibhushan this year | Netaji's Rashtrapati Bhawan portrait sparks row; TMC MP deletes tweet after claiming it resembles actor Prosenjit | Govt remains singularly devoted to farmers’ welfare, says Prez Kovind in address to nation | Groping without skin-to-skin contact not sexual assault: Bombay HC | Indian, Chinese soldiers clash in Sikkim's Naku La, injuries reported on both sides
West Bengal Guv Jagdeep Dhankhar inaugurates phase 3 trial of Covaxin in Kolkata Covid-19 Vaccine
Image Credit: Jagdeep Dhankhar Twitter

West Bengal Guv Jagdeep Dhankhar inaugurates phase 3 trial of Covaxin in Kolkata

India Blooms News Service | @indiablooms | 02 Dec 2020, 12:49 pm

Kolkata/IBNS: West Bengal Governor Jagdeep Dhankhar on Wednesday inaugurated the third phase trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

Dhankhar inaugurated the vaccine trial at Kolkata's National Institute of Cholera and Enteric Disease (NICED) here at 11 am.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, will be taking the first dose of Covaxin, media reports said.

Though Prime Minister Narendra Modi had stressed on vaccines for all, India's Health Secretary Rajesh Bhushan on Tuesday said the government never spoke about vaccination for the entire country.

"I just want to make this clear that the government has never spoken about vaccinating the entire country. It's important that we discuss such scientific issues, based on factual information only," the Health Secretary replied when asked how much time it would take to vaccinate the entire country during a press briefing in the national capital.

"If we're able to vaccinate a critical mass of people and break the virus transmission, then we may not have to vaccinate the entire population," added Dr Balram Bhargava, Indian Council of Medical Research Director-General, who was present.